KALA vs SOFI · $54.3M cap vs P/E 39, rev $283.1M
Kala Pharmaceuticals Inc (KALA) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
KALA currently screens at market cap $54.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the KALA and SOFI stock pages for the full models.
Not investment advice.